(Q37192537)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

John S Lubel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Peter W Angus

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

28 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1327-1338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18557800%20AND%20SRC:MED&resulttype=core&format=json

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Liver fibrosis: a balance of ACEs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05461.X

Renin-angiotensin system inhibition: how much is too much of a good thing?

21 January 2018

1 reference

12 December 2020

The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)

1 reference

12 December 2020

Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

1 reference

12 December 2020

Fate of bradykinin on the rat liver when administered by the venous or arterial route.

1 reference

12 December 2020

The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan

1 reference

12 December 2020

Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis

1 reference

12 December 2020

AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers

1 reference

12 December 2020

Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis

1 reference

12 December 2020

[The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt]

1 reference

12 December 2020

Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis

1 reference

12 December 2020

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

1 reference

12 December 2020

Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy

1 reference

12 December 2020

Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan

1 reference

12 December 2020

Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide

1 reference

12 December 2020

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

1 reference

12 December 2020

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

1 reference

12 December 2020

Hepatic conversion of angiotensin I and the portal hypertensive response to angiotensin II in normal and regenerating liver

1 reference

12 December 2020

Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists

1 reference

12 December 2020

Converting enzyme determines plasma clearance of angiotensin-(1-7)

1 reference

12 December 2020

Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects

1 reference

12 December 2020

Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor

1 reference

12 December 2020

The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:effects of RAS inhibitors on hepatic fibrosis induced by CCl(4).

1 reference

12 December 2020

Effects of captopril on renal function in patients with cirrhosis and ascites

1 reference

12 December 2020

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor

1 reference

12 December 2020

Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

1 reference

12 December 2020

Angiotensin II induces contraction and proliferation of human hepatic stellate cells

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease

1 reference

12 December 2020

Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system

1 reference

12 December 2020

A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension

1 reference

12 December 2020

Evidence for a new angiotensin-(1–7) receptor subtype in the aorta of Sprague–Dawley rats

1 reference

12 December 2020

Purification and properties of angiotensin-converting enzyme from hog lung

1 reference

12 December 2020

Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis

1 reference

12 December 2020

Modern management of portal hypertension

1 reference

12 December 2020

Effect of enalapril treatment and sclerotherapy of esophageal varices on hepatic hemodynamics in portal hypertension

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

1 reference

12 December 2020

Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis

1 reference

12 December 2020

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.

1 reference

12 December 2020

Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.

1 reference

12 December 2020

Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition

1 reference

12 December 2020

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

1 reference

12 December 2020

Angiotensin-(1-7)-Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells

1 reference

12 December 2020

Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system

1 reference

12 December 2020

Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition

1 reference

12 December 2020

AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4).

1 reference

12 December 2020

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

1 reference

12 December 2020

Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis

1 reference

12 December 2020

Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery

1 reference

12 December 2020

Biochemistry and kinetics of the renin-angiotensin system

1 reference

12 December 2020

Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme

1 reference

12 December 2020

Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist

1 reference

12 December 2020

Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).

1 reference

12 December 2020

Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system

1 reference

12 December 2020

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

1 reference

12 December 2020

ACE2, a new regulator of the renin-angiotensin system

1 reference

12 December 2020

Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis

1 reference

12 December 2020

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

1 reference

12 December 2020

Angiotensin II Receptors and Functional Correlates

1 reference

12 December 2020

Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity

1 reference

12 December 2020

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

1 reference

12 December 2020

Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.

1 reference

12 December 2020

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension

1 reference

12 December 2020

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

1 reference

12 December 2020

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

1 reference

12 December 2020

Hepatic chymase level in chronic hepatitis: co-localization of chymase with fibrosis

1 reference

12 December 2020

Angiotensin-(1-7) inhibits vascular smooth muscle cell growth

1 reference

12 December 2020

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

1 reference

12 December 2020

Angiotensin IV in the central nervous system.

1 reference

12 December 2020

Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver.

1 reference

12 December 2020

Diagnostic Significance of Serum Angiotensin-Converting Enzyme Activity in Biochemical Tests with Special Reference to Chronic Liver Diseases

1 reference

12 December 2020

Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control

1 reference

12 December 2020

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide

1 reference

12 December 2020

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors

1 reference

12 December 2020

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

1 reference

12 December 2020

Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

1 reference

12 December 2020

Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites.

1 reference

12 December 2020

Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).

1 reference

12 December 2020

The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats

1 reference

12 December 2020

Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.

1 reference

12 December 2020

Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis

1 reference

12 December 2020

Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

1 reference

12 December 2020

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

12 December 2020

Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis.

1 reference

12 December 2020

Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy

1 reference

12 December 2020

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

1 reference

12 December 2020

Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study.

1 reference

12 December 2020

Angiotensin-(1-7) reduces smooth muscle growth after vascular injury

1 reference

12 December 2020

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

1 reference

12 December 2020

A local pancreatic renin-angiotensin system: endocrine and exocrine roles

1 reference

12 December 2020

Hepatic stellate cells as a target for the treatment of liver fibrosis

1 reference

12 December 2020

Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition

1 reference

12 December 2020

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

1 reference

12 December 2020

Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus

1 reference

12 December 2020

Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats

1 reference

12 December 2020

Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis

1 reference

12 December 2020

Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension

1 reference

12 December 2020

Significance of chymase-dependent angiotensin II formation in the progression of human liver fibrosis

1 reference

12 December 2020

Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts

1 reference

12 December 2020

Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade

1 reference

12 December 2020

Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues

1 reference

12 December 2020

Vascular endothelial dysfunction in cirrhosis

1 reference

12 December 2020

Renin, aldosterone and renal haemodynamics in cirrhosis with ascites

1 reference

12 December 2020